1
|
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
|
N Engl J Med
|
2009
|
17.17
|
2
|
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
|
N Engl J Med
|
2003
|
13.29
|
3
|
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
|
N Engl J Med
|
2014
|
10.54
|
4
|
Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention.
|
Circulation
|
2002
|
4.99
|
5
|
Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia.
|
J Am Coll Cardiol
|
2004
|
4.62
|
6
|
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2014
|
4.57
|
7
|
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.
|
Lancet
|
2013
|
4.34
|
8
|
Drug-eluting coronary-artery stents.
|
N Engl J Med
|
2013
|
3.69
|
9
|
Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis.
|
J Am Coll Cardiol
|
2011
|
3.66
|
10
|
Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.
|
J Am Soc Nephrol
|
2010
|
3.47
|
11
|
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.
|
Lancet
|
2013
|
3.41
|
12
|
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial.
|
Eur Heart J
|
2011
|
3.29
|
13
|
Incidence, retrieval methods, and outcomes of stent loss during percutaneous coronary intervention: a large single-center experience.
|
Catheter Cardiovasc Interv
|
2005
|
3.20
|
14
|
Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.
|
Thromb Haemost
|
2011
|
3.16
|
15
|
Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation.
|
J Am Coll Cardiol
|
2007
|
2.88
|
16
|
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score.
|
Circulation
|
2013
|
2.88
|
17
|
Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events.
|
Circulation
|
2003
|
2.81
|
18
|
Transcatheter aortic valve implantation: assessing the learning curve.
|
JACC Cardiovasc Interv
|
2011
|
2.63
|
19
|
Myocardial bridging.
|
Eur Heart J
|
2005
|
2.56
|
20
|
Trends in cause of death after percutaneous coronary intervention.
|
Circulation
|
2014
|
2.52
|
21
|
Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease.
|
J Am Coll Cardiol
|
2003
|
2.52
|
22
|
Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003.
|
J Am Coll Cardiol
|
2005
|
2.51
|
23
|
Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
|
JACC Cardiovasc Interv
|
2010
|
2.51
|
24
|
Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial.
|
J Am Coll Cardiol
|
2007
|
2.47
|
25
|
Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol.
|
Circulation
|
2007
|
2.47
|
26
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.
|
J Am Coll Cardiol
|
2012
|
2.44
|
27
|
Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
|
Circulation
|
2008
|
2.42
|
28
|
Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
|
Am Heart J
|
2004
|
2.42
|
29
|
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.
|
Circulation
|
2010
|
2.40
|
30
|
Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke.
|
JAMA
|
2004
|
2.32
|
31
|
Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents.
|
Circulation
|
2007
|
2.31
|
32
|
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2014
|
2.30
|
33
|
Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era.
|
Circulation
|
2006
|
2.29
|
34
|
Chronic total occlusion angioplasty in the United States.
|
JACC Cardiovasc Interv
|
2009
|
2.24
|
35
|
Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study.
|
J Am Coll Cardiol
|
2005
|
2.21
|
36
|
Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: a randomized study (ATLAS).
|
Circulation
|
2003
|
2.21
|
37
|
Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents.
|
Mayo Clin Proc
|
2004
|
2.11
|
38
|
2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2014
|
2.04
|
39
|
Volume-outcome relationships for percutaneous coronary interventions in the stent era.
|
Circulation
|
2005
|
2.03
|
40
|
The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.
|
J Am Coll Cardiol
|
2002
|
2.03
|
41
|
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
|
Am Heart J
|
2010
|
2.00
|
42
|
Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory.
|
Circulation
|
2002
|
2.00
|
43
|
Rheolytic thrombectomy with Angiojet in thrombus-containing lesions.
|
Catheter Cardiovasc Interv
|
2002
|
1.98
|
44
|
The history of the German Cardiac Society and the American College of Cardiology and their two founders.
|
J Am Coll Cardiol
|
2013
|
1.97
|
45
|
ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2010
|
1.92
|
46
|
Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
|
J Am Coll Cardiol
|
2007
|
1.91
|
47
|
Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.
|
J Am Coll Cardiol
|
2006
|
1.90
|
48
|
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes.
|
Circulation
|
2002
|
1.88
|
49
|
Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions.
|
Circulation
|
2004
|
1.87
|
50
|
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke).
|
Circulation
|
2012
|
1.87
|
51
|
Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice.
|
J Am Coll Cardiol
|
2009
|
1.87
|
52
|
ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association.
|
Circulation
|
2010
|
1.86
|
53
|
A risk score to predict in-hospital mortality for percutaneous coronary interventions.
|
J Am Coll Cardiol
|
2006
|
1.84
|
54
|
Clinical determinants of radiation dose in percutaneous coronary interventional procedures: influence of patient size, procedure complexity, and performing physician.
|
JACC Cardiovasc Interv
|
2011
|
1.80
|
55
|
Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience.
|
J Am Coll Cardiol
|
2008
|
1.78
|
56
|
Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
|
Circulation
|
2012
|
1.77
|
57
|
Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents.
|
Circulation
|
2008
|
1.77
|
58
|
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
|
Eur J Cardiothorac Surg
|
2011
|
1.77
|
59
|
Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice.
|
Eur Heart J
|
2013
|
1.76
|
60
|
Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography.
|
Mayo Clin Proc
|
2002
|
1.74
|
61
|
Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research.
|
JACC Cardiovasc Interv
|
2010
|
1.74
|
62
|
Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry.
|
J Am Coll Cardiol
|
2003
|
1.74
|
63
|
Coronary stent restenosis in patients treated with cilostazol.
|
Circulation
|
2005
|
1.73
|
64
|
Factors associated with 30-day readmission rates after percutaneous coronary intervention.
|
Arch Intern Med
|
2011
|
1.70
|
65
|
Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic.
|
J Am Coll Cardiol
|
2007
|
1.68
|
66
|
Efficacy and safety of atrasentan in patients with cardiovascular risk and early atherosclerosis.
|
Hypertension
|
2008
|
1.67
|
67
|
Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
|
JACC Cardiovasc Interv
|
2011
|
1.66
|
68
|
The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial.
|
Am Heart J
|
2006
|
1.65
|
69
|
Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina.
|
Eur Heart J
|
2006
|
1.63
|
70
|
Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry.
|
J Am Coll Cardiol
|
2002
|
1.62
|
71
|
Myocardial bridging in adult patients with hypertrophic cardiomyopathy.
|
J Am Coll Cardiol
|
2003
|
1.62
|
72
|
Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
|
Am Heart J
|
2004
|
1.60
|
73
|
Long-term mortality of coronary artery bypass grafting and bare-metal stenting.
|
Ann Thorac Surg
|
2011
|
1.60
|
74
|
30-day readmission for patients undergoing percutaneous coronary interventions in New York state.
|
JACC Cardiovasc Interv
|
2011
|
1.59
|
75
|
Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain?
|
J Am Coll Cardiol
|
2003
|
1.59
|
76
|
Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering.
|
Circulation
|
2002
|
1.57
|
77
|
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary.
|
Circ Cardiovasc Interv
|
2011
|
1.56
|
78
|
The truth and consequences of the COURAGE trial.
|
J Am Coll Cardiol
|
2007
|
1.55
|
79
|
Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents.
|
Circulation
|
2004
|
1.54
|
80
|
Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?
|
JAMA
|
2005
|
1.54
|
81
|
Sex differences in atheroma burden and endothelial function in patients with early coronary atherosclerosis.
|
Eur Heart J
|
2008
|
1.53
|
82
|
Medical device innovation: prospective solutions for an ecosystem in crisis. Adding a professional society perspective.
|
JACC Cardiovasc Interv
|
2012
|
1.53
|
83
|
Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York.
|
Circulation
|
2012
|
1.52
|
84
|
Percutaneous coronary intervention at centers with and without on-site surgery: a meta-analysis.
|
JAMA
|
2011
|
1.51
|
85
|
Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
|
Catheter Cardiovasc Interv
|
2012
|
1.51
|
86
|
Staged versus one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction.
|
Circ Cardiovasc Interv
|
2013
|
1.51
|
87
|
Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.
|
Circulation
|
2004
|
1.51
|
88
|
Turf wars and silos-joined at the hip: what can be done?
|
Catheter Cardiovasc Interv
|
2007
|
1.50
|
89
|
Low-risk percutaneous coronary interventions without on-site cardiac surgery: two years' observational experience and follow-up.
|
Am Heart J
|
2003
|
1.50
|
90
|
Location of femoral artery access and correlation with vascular complications.
|
Catheter Cardiovasc Interv
|
2011
|
1.50
|
91
|
Clinical practice. Hypertrophic obstructive cardiomyopathy.
|
N Engl J Med
|
2004
|
1.50
|
92
|
Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons.
|
Ann Thorac Surg
|
2011
|
1.49
|
93
|
Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction.
|
JACC Cardiovasc Interv
|
2008
|
1.49
|
94
|
Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention.
|
JAMA
|
2011
|
1.48
|
95
|
Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon.
|
Catheter Cardiovasc Interv
|
2004
|
1.48
|
96
|
Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry.
|
Ann Thorac Surg
|
2016
|
1.48
|
97
|
Immediate ambulation following diagnostic coronary angiography procedures utilizing a vascular closure device (The Closer).
|
J Invasive Cardiol
|
2002
|
1.47
|
98
|
Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization.
|
Am Heart J
|
2004
|
1.47
|
99
|
Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents.
|
JACC Cardiovasc Interv
|
2010
|
1.47
|
100
|
Statistical SPECT processing in MRI-negative epilepsy surgery.
|
Neurology
|
2014
|
1.46
|
101
|
Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients.
|
Circ Cardiovasc Interv
|
2008
|
1.45
|
102
|
The New York State risk score for predicting in-hospital/30-day mortality following percutaneous coronary intervention.
|
JACC Cardiovasc Interv
|
2013
|
1.45
|
103
|
Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures.
|
Am Heart J
|
2004
|
1.43
|
104
|
Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
|
JACC Cardiovasc Interv
|
2013
|
1.42
|
105
|
Economic and clinical outcomes of a physician-led continuous quality improvement intervention in the delivery of percutaneous coronary intervention.
|
Am J Manag Care
|
2006
|
1.42
|
106
|
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization : a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology. Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.
|
Catheter Cardiovasc Interv
|
2009
|
1.41
|
107
|
Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions.
|
Am Heart J
|
2003
|
1.41
|
108
|
Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention.
|
J Am Coll Cardiol
|
2007
|
1.40
|
109
|
Neuroimaging patterns of ischemic stroke after percutaneous coronary intervention.
|
Catheter Cardiovasc Interv
|
2014
|
1.40
|
110
|
Sustaining improvement in door-to-balloon time over 4 years: the Mayo clinic ST-elevation myocardial infarction protocol.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
1.40
|
111
|
Outcomes for patients with ST-elevation myocardial infarction in hospitals with and without onsite coronary artery bypass graft surgery: the New York State experience.
|
Circ Cardiovasc Interv
|
2009
|
1.40
|
112
|
Percutaneous coronary intervention for ST-segment and non-ST-segment elevation myocardial infarction at hospitals with and without on-site cardiac surgical capability.
|
Mayo Clin Proc
|
2004
|
1.40
|
113
|
Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory.
|
J Am Coll Cardiol
|
2008
|
1.39
|
114
|
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents.
|
Catheter Cardiovasc Interv
|
2008
|
1.39
|
115
|
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry.
|
JACC Cardiovasc Interv
|
2011
|
1.39
|
116
|
Safety and efficacy of cutting balloon angioplasty: the Mayo Clinic experience.
|
J Invasive Cardiol
|
2002
|
1.39
|
117
|
Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation.
|
Circulation
|
2005
|
1.38
|
118
|
Survival benefit with concomitant clopidogrel and glycoprotein IIb/IIIa inhibitor therapy at ad hoc percutaneous coronary intervention.
|
Mayo Clin Proc
|
2008
|
1.38
|
119
|
Magnetic navigation facilitates percutaneous coronary intervention for complex lesions.
|
Catheter Cardiovasc Interv
|
2013
|
1.38
|
120
|
Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: a quantitative intravascular ultrasound analysis.
|
Am Heart J
|
2007
|
1.38
|
121
|
Percutaneous coronary intervention in native vessels with angiographically visible thrombus temporal trends and impact of drug-eluting stents.
|
JACC Cardiovasc Interv
|
2010
|
1.38
|
122
|
Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion.
|
Circulation
|
2009
|
1.37
|
123
|
Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
|
Eur Heart J
|
2010
|
1.36
|
124
|
Percutaneous closure of congenital coronary artery fistulae: results and angiographic follow-up.
|
JACC Cardiovasc Interv
|
2011
|
1.32
|
125
|
Transcatheter valve therapy a professional society overview from the american college of cardiology foundation and the society of thoracic surgeons.
|
J Am Coll Cardiol
|
2011
|
1.30
|
126
|
Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention.
|
J Am Coll Cardiol
|
2002
|
1.29
|
127
|
Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).
|
Am J Cardiol
|
2010
|
1.27
|
128
|
Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.
|
J Am Coll Cardiol
|
2009
|
1.26
|
129
|
Somatostatin analog therapy for severe polycystic liver disease: results after 2 years.
|
Nephrol Dial Transplant
|
2012
|
1.20
|
130
|
Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries.
|
Circulation
|
2004
|
1.20
|
131
|
Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores.
|
Mayo Clin Proc
|
2007
|
1.19
|
132
|
Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry.
|
Am Heart J
|
2003
|
1.19
|
133
|
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.
|
J Am Coll Cardiol
|
2006
|
1.18
|
134
|
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
|
Eur Heart J
|
2007
|
1.17
|
135
|
Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry.
|
J Am Coll Cardiol
|
2002
|
1.15
|
136
|
Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes.
|
JACC Cardiovasc Interv
|
2009
|
1.13
|
137
|
Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
|
Eur Heart J
|
2011
|
1.13
|
138
|
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.
|
Am Heart J
|
2006
|
1.10
|
139
|
Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience.
|
Circulation
|
2007
|
1.10
|
140
|
Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents.
|
Anesthesiology
|
2008
|
1.10
|
141
|
Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.
|
J Am Coll Cardiol
|
2005
|
1.10
|
142
|
Intravascular ultrasound for intracranial angioplasty and stent placement: technical case report.
|
Neurosurgery
|
2006
|
1.10
|
143
|
Prediction of complications following nonemergency percutaneous coronary interventions.
|
Am J Cardiol
|
2005
|
1.09
|
144
|
ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.
|
J Thorac Cardiovasc Surg
|
2012
|
1.09
|
145
|
Appropriateness of coronary revascularization for patients without acute coronary syndromes.
|
J Am Coll Cardiol
|
2012
|
1.08
|
146
|
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis.
|
Circulation
|
2002
|
1.08
|
147
|
Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.
|
Anesthesiology
|
2008
|
1.07
|
148
|
Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005.
|
JACC Cardiovasc Interv
|
2008
|
1.07
|
149
|
Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years.
|
J Thorac Cardiovasc Surg
|
2011
|
1.07
|
150
|
Left main coronary artery stenosis: state-of-the-art.
|
Curr Probl Cardiol
|
2007
|
1.07
|
151
|
Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions.
|
JACC Cardiovasc Interv
|
2009
|
1.07
|
152
|
Safety and efficacy of drug-eluting stent for ST-segment elevation myocardial infarction in an unselected consecutive cohort.
|
Catheter Cardiovasc Interv
|
2008
|
1.07
|
153
|
Response to letter regarding article, "Quantification of incomplete revascularization and its association with five-year mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial: validation of the residual SYNTAX Score".
|
Circulation
|
2014
|
1.05
|
154
|
Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents.
|
Circulation
|
2005
|
1.04
|
155
|
Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator.
|
J Am Coll Cardiol
|
2005
|
1.04
|
156
|
ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee.
|
Circulation
|
2011
|
1.04
|
157
|
The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies.
|
J Am Coll Cardiol
|
2013
|
1.04
|
158
|
Effect of lesion length on fractional flow reserve in intermediate coronary lesions.
|
Am Heart J
|
2005
|
1.03
|
159
|
Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events.
|
J Am Coll Cardiol
|
2006
|
1.02
|
160
|
A total of 1,007 percutaneous coronary interventions without onsite cardiac surgery: acute and long-term outcomes.
|
J Am Coll Cardiol
|
2006
|
1.01
|
161
|
Adjunctive thrombectomy and distal protection in primary percutaneous coronary intervention: impact on microvascular perfusion and outcomes.
|
Circulation
|
2009
|
1.01
|
162
|
Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
|
J Am Coll Cardiol
|
2004
|
1.00
|
163
|
Chronic coronary artery disease: diagnosis and management.
|
Mayo Clin Proc
|
2009
|
1.00
|
164
|
Comparison of Mayo Clinic risk score and American College of Cardiology/American Heart Association lesion classification in the prediction of adverse cardiovascular outcome following percutaneous coronary interventions.
|
J Am Coll Cardiol
|
2004
|
1.00
|
165
|
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke).
|
J Am Coll Cardiol
|
2012
|
0.99
|
166
|
Intravascular ultrasound identification of intraluminal embolic plaque material during carotid angioplasty with stenting.
|
Catheter Cardiovasc Interv
|
2006
|
0.99
|
167
|
Early direct coronary angioplasty in survivors of out-of-hospital cardiac arrest.
|
Am J Cardiol
|
2003
|
0.99
|
168
|
Circadian variation in coronary stent thrombosis.
|
JACC Cardiovasc Interv
|
2011
|
0.99
|
169
|
Association of body mass index with outcome after percutaneous coronary intervention.
|
Am J Cardiol
|
2003
|
0.99
|
170
|
"Familial" apical ballooning syndrome (Takotsubo cardiomyopathy).
|
Int J Cardiol
|
2009
|
0.99
|
171
|
Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting.
|
J Am Coll Cardiol
|
2002
|
0.98
|
172
|
Rational dispersion for the introduction of transcatheter valve therapy.
|
JAMA
|
2011
|
0.98
|
173
|
Temporal trends (over 30 years), clinical characteristics, outcomes, and gender in patients ≤50 years of age having percutaneous coronary intervention.
|
Am J Cardiol
|
2011
|
0.98
|
174
|
Trends in the association between age and in-hospital mortality after percutaneous coronary intervention: National Cardiovascular Data Registry experience.
|
Circ Cardiovasc Interv
|
2009
|
0.97
|
175
|
Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair.
|
Atherosclerosis
|
2002
|
0.97
|
176
|
Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris.
|
Atherosclerosis
|
2002
|
0.97
|
177
|
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials.
|
Am Heart J
|
2003
|
0.96
|
178
|
How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease?
|
Eur Heart J
|
2010
|
0.96
|
179
|
Clinical and angiographic predictors of restenosis after percutaneous coronary intervention: insights from the Prevention of Restenosis With Tranilast and Its Outcomes (PRESTO) trial.
|
Circulation
|
2004
|
0.96
|
180
|
Safety of same-day coronary angiography in patients undergoing elective valvular heart surgery.
|
Mayo Clin Proc
|
2007
|
0.96
|
181
|
Successful radiofrequency ablation of the cerebral cortex in pigs using the venous system: possible implications for treating CNS disorders.
|
Epilepsy Res
|
2008
|
0.95
|
182
|
Differences in utilization of drug-eluting stents by race and payer.
|
Am J Cardiol
|
2007
|
0.95
|
183
|
The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease.
|
Eur Heart J
|
2013
|
0.94
|
184
|
Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs.
|
Cardiovasc Res
|
2002
|
0.94
|
185
|
Simvastatin preserves myocardial perfusion and coronary microvascular permeability in experimental hypercholesterolemia independent of lipid lowering.
|
J Am Coll Cardiol
|
2002
|
0.94
|
186
|
Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy.
|
Transplantation
|
2006
|
0.94
|
187
|
Coronary artery fistula: single-center experience spanning 17 years.
|
J Interv Cardiol
|
2007
|
0.93
|
188
|
Recent trends in the percutaneous treatment of chronic total coronary occlusions.
|
Am J Cardiol
|
2006
|
0.93
|
189
|
Comparison of survival after successful percutaneous coronary intervention of patients with diabetes mellitus receiving insulin versus those receiving only diet and/or oral hypoglycemic agents.
|
Am J Cardiol
|
2004
|
0.93
|
190
|
Three-dimensional volumetric computed tomographic scoring as an objective outcome measure for chronic rhinosinusitis: clinical correlations and comparison to Lund-Mackay scoring.
|
Int Forum Allergy Rhinol
|
2013
|
0.93
|
191
|
Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention.
|
Am J Cardiol
|
2004
|
0.92
|
192
|
Routine intravascular ultrasound guidance of percutaneous coronary intervention: a critical reappraisal.
|
J Am Coll Cardiol
|
2004
|
0.92
|
193
|
Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
|
J Am Coll Cardiol
|
2002
|
0.92
|
194
|
Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems.
|
Atherosclerosis
|
2012
|
0.92
|
195
|
Appropriateness of diagnostic catheterization for suspected coronary artery disease in New York State.
|
Circ Cardiovasc Interv
|
2014
|
0.92
|
196
|
Drug-eluting stents: a study of international practice.
|
Am Heart J
|
2009
|
0.92
|
197
|
Risk stratification for long-term mortality after percutaneous coronary intervention.
|
Circ Cardiovasc Interv
|
2014
|
0.92
|
198
|
Effect of onset-to-door time and door-to-balloon time on mortality in patients undergoing percutaneous coronary interventions for st-segment elevation myocardial infarction.
|
Am J Cardiol
|
2010
|
0.91
|
199
|
Management of pulmonary vein rupture after percutaneous intervention: utility of a hybrid approach.
|
Ann Thorac Surg
|
2013
|
0.91
|
200
|
Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI Dynamic Registry.
|
J Interv Cardiol
|
2007
|
0.91
|
201
|
Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials).
|
Am J Cardiol
|
2006
|
0.91
|
202
|
Accuracy considerations in image-guided cardiac interventions: experience and lessons learned.
|
Int J Comput Assist Radiol Surg
|
2011
|
0.90
|
203
|
The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial.
|
J Am Coll Cardiol
|
2012
|
0.90
|
204
|
Impact of incomplete revascularization on long-term mortality after coronary stenting.
|
Circ Cardiovasc Interv
|
2011
|
0.90
|
205
|
Clinical risk stratification in the emergency department predicts long-term cardiovascular outcomes in a population-based cohort presenting with acute chest pain: primary results of the Olmsted county chest pain study.
|
Medicine (Baltimore)
|
2009
|
0.90
|
206
|
Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry).
|
Am J Cardiol
|
2002
|
0.90
|
207
|
From randomized trials to registry studies: translating data into clinical information.
|
Nat Clin Pract Cardiovasc Med
|
2008
|
0.90
|
208
|
Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.
|
J Am Coll Cardiol
|
2005
|
0.89
|
209
|
Independent association between symptom onset time and infarct size in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
|
Chronobiol Int
|
2014
|
0.89
|
210
|
Radiation dose reduction in the invasive cardiovascular laboratory: implementing a culture and philosophy of radiation safety.
|
JACC Cardiovasc Interv
|
2012
|
0.89
|
211
|
Infectious complications of percutaneous vascular closure devices.
|
Mayo Clin Proc
|
2005
|
0.88
|
212
|
Alveolar hemorrhage associated with periprocedural eptifibatide administration.
|
J Invasive Cardiol
|
2004
|
0.88
|
213
|
Drug-eluting stents in octogenarians: early and intermediate outcome.
|
Am Heart J
|
2008
|
0.88
|
214
|
ACCF 2008 Training Statement on Multimodality Noninvasive Cardiovascular Imaging A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the American Society of Echocardiography, the American Society of Nuclear Cardiology, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine.
|
J Am Coll Cardiol
|
2009
|
0.88
|
215
|
Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes.
|
J Am Coll Cardiol
|
2002
|
0.88
|
216
|
ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training.
|
J Am Coll Cardiol
|
2007
|
0.88
|
217
|
Carotid artery stenting versus surgery: adequate comparisons?
|
Lancet Neurol
|
2010
|
0.87
|
218
|
Temporal trends and improved outcomes of percutaneous coronary revascularization in nonagenarians.
|
JACC Cardiovasc Interv
|
2008
|
0.87
|
219
|
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
|
Eur Heart J
|
2012
|
0.86
|
220
|
Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial.
|
J Am Coll Cardiol
|
2004
|
0.86
|
221
|
Procedural factors associated with percutaneous coronary intervention-related ischemic stroke.
|
JACC Cardiovasc Interv
|
2012
|
0.86
|
222
|
Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease.
|
Circ Cardiovasc Interv
|
2012
|
0.86
|
223
|
A critical appraisal of current models of risk stratification for percutaneous coronary interventions.
|
Am Heart J
|
2005
|
0.86
|
224
|
An invasive strategy is associated with decreased mortality in patients with unstable angina and non-ST-elevation myocardial infarction: GUSTO IIb trial.
|
Am J Med
|
2003
|
0.86
|
225
|
Strain rate imaging for assessment of regional myocardial function: results from a clinical model of septal ablation.
|
Circulation
|
2002
|
0.86
|
226
|
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial.
|
Eur Heart J
|
2010
|
0.86
|
227
|
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke).
|
Eur Heart J
|
2012
|
0.86
|
228
|
Chronic kidney disease as a cardiovascular risk factor.
|
Am Heart J
|
2003
|
0.85
|
229
|
A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease).
|
Angiology
|
2006
|
0.85
|
230
|
Task force 3: training in diagnostic and interventional cardiac catheterization endorsed by the Society for Cardiovascular Angiography and Interventions.
|
J Am Coll Cardiol
|
2008
|
0.85
|
231
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
|
Catheter Cardiovasc Interv
|
2012
|
0.85
|
232
|
Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.
|
Eur Heart J
|
2007
|
0.85
|
233
|
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
|
Eur Heart J
|
2009
|
0.85
|
234
|
Outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (from the PRESTO Trial).
|
Am J Cardiol
|
2005
|
0.85
|
235
|
Balloon aortic valvuloplasty under temporary mechanical circulatory support as a bridge to aortic valve replacement in a patient with hemodynamic failure secondary to critical aortic valve stenosis.
|
Heart Surg Forum
|
2012
|
0.85
|
236
|
Left atrial appendage closure.
|
Curr Cardiol Rep
|
2010
|
0.85
|
237
|
Trends, predictors, and outcomes of cerebrovascular events related to percutaneous coronary intervention: a 16-year single-center experience.
|
JACC Cardiovasc Interv
|
2011
|
0.85
|
238
|
Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment.
|
Am Heart J
|
2003
|
0.84
|
239
|
Centerline tracking for quantification of reverse structural remodeling of the pulmonary veins following cardiac ablation therapy.
|
Acad Radiol
|
2012
|
0.84
|
240
|
Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes.
|
Am Heart J
|
2004
|
0.84
|
241
|
In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction.
|
Am J Cardiol
|
2005
|
0.84
|
242
|
Rationale for on-site cardiac surgery for primary angioplasty: a time for reappraisal.
|
J Am Coll Cardiol
|
2002
|
0.84
|
243
|
A pathobiologic link between risk factors profile and morphological markers of carotid instability.
|
Atherosclerosis
|
2009
|
0.84
|
244
|
Drug-eluting coronary stents.
|
Curr Probl Cardiol
|
2006
|
0.84
|
245
|
Left atrial appendage occlusion for stroke prevention.
|
Curr Probl Cardiol
|
2012
|
0.83
|
246
|
Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
|
Am J Cardiol
|
2008
|
0.83
|
247
|
Outcomes in diabetics undergoing revascularization: the long and the short of it.
|
J Am Coll Cardiol
|
2002
|
0.83
|
248
|
C-reactive protein relaxes human vessels in vitro.
|
Arterioscler Thromb Vasc Biol
|
2002
|
0.83
|
249
|
Is the left atrial appendage more than a simple appendage?
|
Catheter Cardiovasc Interv
|
2009
|
0.82
|
250
|
A tissue-engineered stent for cell-based vascular gene transfer.
|
Hum Gene Ther
|
2002
|
0.82
|
251
|
On mixed reality environments for minimally invasive therapy guidance: systems architecture, successes and challenges in their implementation from laboratory to clinic.
|
Comput Med Imaging Graph
|
2013
|
0.82
|
252
|
Dendroaspis natriuretic peptide relaxes isolated human arteries and veins.
|
Cardiovasc Res
|
2002
|
0.82
|
253
|
Prevention and management of contrast-induced acute kidney injury.
|
Curr Treat Options Cardiovasc Med
|
2012
|
0.82
|
254
|
3-Dimensional bifurcation angle analysis in patients with left main disease: a substudy of the SYNTAX trial (SYNergy Between Percutaneous Coronary Intervention with TAXus and Cardiac Surgery).
|
JACC Cardiovasc Interv
|
2010
|
0.82
|
255
|
Location of coronary culprit lesions at autopsy in 41 nondiabetic patients with acute myocardial infarction.
|
Am J Forensic Med Pathol
|
2010
|
0.82
|
256
|
Incomplete revascularization is associated with greater risk of long-term mortality after stenting in the era of first generation drug-eluting stents.
|
Am J Cardiol
|
2013
|
0.82
|
257
|
Pilot multi-reader study demonstrating potential for dose reduction in dual energy hepatic CT using non-linear blending of mixed kV image datasets.
|
Eur Radiol
|
2010
|
0.82
|
258
|
Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions <or=40%, 41% to 49%, and >or=50% having percutaneous coronary revascularization.
|
Am J Cardiol
|
2003
|
0.82
|
259
|
Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
|
Am J Cardiol
|
2006
|
0.81
|
260
|
Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
|
JACC Cardiovasc Interv
|
2012
|
0.81
|
261
|
Proteinuria, serum creatinine, and outcome of percutaneous coronary intervention in patients with diabetes mellitus.
|
Am J Cardiol
|
2002
|
0.81
|
262
|
A comparison of mortality, myocardial infarction, and repeated revascularization for sirolimus-eluting and paclitaxel-eluting coronary stents.
|
Am Heart J
|
2007
|
0.81
|
263
|
The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI).
|
Ann Thorac Surg
|
2005
|
0.81
|
264
|
Electromagnetic interference of magnetic field based auto identification technologies in healthcare settings.
|
Int J Med Inform
|
2011
|
0.81
|
265
|
Current management of non-ST-segment-elevation acute coronary syndrome: reconciling the results of randomized controlled trials.
|
Eur Heart J
|
2003
|
0.81
|
266
|
Relation of preprocedural statin therapy to in-hospital procedural complications following percutaneous coronary interventions in patients with hyperlipidemia.
|
Am J Cardiol
|
2006
|
0.81
|
267
|
Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia.
|
Atherosclerosis
|
2003
|
0.81
|
268
|
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
|
JACC Cardiovasc Interv
|
2010
|
0.81
|
269
|
Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction.
|
Am J Cardiol
|
2008
|
0.81
|
270
|
The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy.
|
EuroIntervention
|
2013
|
0.81
|
271
|
Intracardiac echocardiography in the interventional catheterization laboratory: preliminary experience with a novel, phased-array transducer.
|
Am J Cardiol
|
2002
|
0.80
|
272
|
Drug-eluting coronary-artery stents.
|
N Engl J Med
|
2013
|
0.80
|
273
|
Abnormal coronary microvascular endothelial function in humans with asymptomatic left ventricular dysfunction.
|
Am Heart J
|
2003
|
0.80
|
274
|
Underutilization of percutaneous coronary intervention for ST-elevation myocardial infarction in medicaid patients relative to private insurance patients.
|
J Interv Cardiol
|
2013
|
0.80
|
275
|
Left atrial appendage obliteration: mechanisms of healing and intracardiac integration.
|
JACC Cardiovasc Interv
|
2010
|
0.80
|
276
|
Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry.
|
JACC Cardiovasc Interv
|
2010
|
0.80
|
277
|
Development and validation of risk adjustment models for long-term mortality and myocardial infarction following percutaneous coronary interventions.
|
Circ Cardiovasc Interv
|
2010
|
0.80
|
278
|
Relation of Thrombolysis in Myocardial Infarction (TIMI) frame count to coronary flow parameters.
|
Am J Cardiol
|
2003
|
0.80
|
279
|
The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA).
|
J Am Coll Cardiol
|
2005
|
0.80
|
280
|
A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
|
JACC Cardiovasc Interv
|
2012
|
0.80
|
281
|
The association of serum uric acid levels with outcomes following percutaneous coronary intervention.
|
J Interv Cardiol
|
2010
|
0.80
|
282
|
A technical and cognitive skills evaluation of performance in interventional cardiology procedures using medical simulation.
|
Simul Healthc
|
2010
|
0.80
|
283
|
And the answer is, it doesn't much matter.
|
Circulation
|
2002
|
0.80
|
284
|
Comparison of drug-eluting and bare-metal stents for stable coronary artery disease.
|
JACC Cardiovasc Interv
|
2009
|
0.80
|
285
|
Drug-drug interactions in cardiovascular catheterizations and interventions.
|
JACC Cardiovasc Interv
|
2012
|
0.79
|
286
|
Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.
|
J Am Coll Cardiol
|
2006
|
0.79
|
287
|
Thirty-year trends in outcomes of percutaneous coronary interventions in diabetic patients.
|
Mayo Clin Proc
|
2013
|
0.79
|
288
|
Eptifibatide vs abciximab as adjunctive therapy during primary percutaneous coronary intervention for acute myocardial infarction.
|
Mayo Clin Proc
|
2007
|
0.79
|
289
|
Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
|
Am J Cardiol
|
2007
|
0.79
|
290
|
TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.
|
Am Heart J
|
2013
|
0.79
|
291
|
Effect of septal ablation on myocardial relaxation and left atrial pressure in hypertrophic cardiomyopathy an invasive hemodynamic study.
|
JACC Cardiovasc Interv
|
2008
|
0.79
|
292
|
Applicability of distal protection for aortocoronary vein graft interventions in clinical practice.
|
Catheter Cardiovasc Interv
|
2004
|
0.79
|
293
|
The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society of Cardiovascular Angiography and Intervention (SCAI).
|
Catheter Cardiovasc Interv
|
2005
|
0.79
|
294
|
The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy.
|
EuroIntervention
|
2013
|
0.79
|
295
|
Sudden cardiac death: epidemiology, circadian variation, and triggers.
|
Curr Probl Cardiol
|
2011
|
0.79
|
296
|
American College of Cardiology/American Heart Association 2006 update of the clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training: developed in collaboration with the Heart Rhythm Society.
|
Circulation
|
2006
|
0.78
|
297
|
Comparison of outcomes for patients receiving drug-eluting versus bare metal stents for non-ST-segment elevation myocardial infarction.
|
Am J Cardiol
|
2011
|
0.78
|
298
|
ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures).
|
J Am Coll Cardiol
|
2007
|
0.78
|
299
|
Feasibility of dose reduction using novel denoising techniques for low kV (80 kV) CT enterography: optimization and validation.
|
Acad Radiol
|
2010
|
0.78
|
300
|
Interventional fellowship in structural and congenital heart disease for adults.
|
JACC Cardiovasc Interv
|
2010
|
0.78
|
301
|
Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris.
|
Am J Cardiol
|
2002
|
0.78
|
302
|
Patent foramen ovale, systemic embolization, and closure.
|
Curr Probl Cardiol
|
2009
|
0.78
|
303
|
The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial).
|
Am J Cardiol
|
2006
|
0.78
|
304
|
Potential applicability and utilization of left atrial appendage occlusion devices in patients with atrial fibrillation.
|
Am Heart J
|
2006
|
0.78
|
305
|
Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.
|
Mayo Clin Proc
|
2010
|
0.78
|
306
|
ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures).
|
Circulation
|
2007
|
0.78
|
307
|
Everolimus-eluting stents and zotarolimus-eluting stents for percutaneous coronary interventions: two-year outcomes in New York State.
|
Catheter Cardiovasc Interv
|
2013
|
0.78
|
308
|
Utility of isoproterenol to provoke outflow tract gradients in patients with hypertrophic cardiomyopathy.
|
Am J Cardiol
|
2007
|
0.78
|
309
|
American College of Cardiology/American Heart Association 2006 update of the clinical competence statement on invasive electrophysiologystudies,catheterablation,andcardioversion: a report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training developed in collaboration with the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2006
|
0.78
|
310
|
Association of race with complications and prognosis following acute coronary syndromes.
|
Am J Cardiol
|
2004
|
0.77
|
311
|
Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
|
Am J Cardiol
|
2005
|
0.77
|
312
|
Importance of the postdischarge interval in assessing major adverse clinical event rates following percutaneous coronary intervention.
|
Am J Cardiol
|
2005
|
0.77
|
313
|
Outcomes after coronary stent implantation in patients with metal allergy.
|
Circ Cardiovasc Interv
|
2012
|
0.77
|
314
|
Temporal variation in inhospital mortality with percutaneous coronary intervention: a report from the National Heart, Lung and Blood Institute Dynamic Registry.
|
Am Heart J
|
2005
|
0.77
|
315
|
Variability in fluoroscopic X-ray exposure in contemporary cardiac catheterization laboratories.
|
J Am Coll Cardiol
|
2006
|
0.77
|
316
|
Impact of prehospital electrocardiogram protocol and immediate catheterization team activation for patients with ST-elevation-myocardial infarction.
|
Circ Cardiovasc Qual Outcomes
|
2011
|
0.77
|
317
|
Outcome and quality of care of patients who have acute myocardial infarction.
|
Med Clin North Am
|
2007
|
0.77
|
318
|
Surgical and percutaneous management of carotid artery stenosis.
|
Curr Probl Cardiol
|
2008
|
0.77
|
319
|
Images in Cardiology Imaging the coronary microcirculation: 3D micro-CT of coronary vasa vasorum.
|
Int J Cardiovasc Intervent
|
1999
|
0.77
|
320
|
Stroke prevention in atrial fibrillation: WATCHMAN versus warfarin.
|
Expert Rev Cardiovasc Ther
|
2009
|
0.77
|
321
|
Improving cardiovascular health: a balance between discovery and delivery.
|
JAMA
|
2013
|
0.77
|
322
|
Beyond the learning curve: transapical versus transfemoral transcatheter aortic valve replacement in the treatment of severe aortic valve stenosis.
|
J Card Surg
|
2014
|
0.77
|
323
|
Sex-related differences in fractional flow reserve-guided treatment.
|
Circ Cardiovasc Interv
|
2013
|
0.77
|
324
|
Time course analysis of gene expression identifies multiple genes with differential expression in patients with in-stent restenosis.
|
BMC Med Genomics
|
2011
|
0.77
|
325
|
Non-surgical left atrial appendage closure for stroke prevention in atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2011
|
0.77
|
326
|
Observer performance for adaptive, image-based denoising and filtered back projection compared to scanner-based iterative reconstruction for lower dose CT enterography.
|
Abdom Imaging
|
2015
|
0.77
|
327
|
The COURAGE trial in perspective.
|
Catheter Cardiovasc Interv
|
2008
|
0.77
|
328
|
Time-trend analysis on the Framingham risk score and prevalence of cardiovascular risk factors in patients undergoing percutaneous coronary intervention without prior history of coronary vascular disease over the last 17 years: a study from the Mayo Clinic PCI registry.
|
Clin Cardiol
|
2014
|
0.77
|
329
|
A longitudinal analysis of outcomes associated with abciximab and eptifibatide in a consecutive series of 3074 percutaneous coronary interventions.
|
Value Health
|
2008
|
0.76
|
330
|
Differential influence of diabetes mellitus on increased jeopardized myocardium after initial angioplasty or bypass surgery: bypass angioplasty revascularization investigation.
|
Circulation
|
2002
|
0.76
|
331
|
Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial.
|
Am Heart J
|
2012
|
0.76
|
332
|
Was your mother right--do we always need to close the door?
|
Circulation
|
2002
|
0.76
|
333
|
Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
|
Catheter Cardiovasc Interv
|
2012
|
0.76
|
334
|
Usefulness of diabetes mellitus to predict long-term outcomes in patients with unstable angina pectoris.
|
Am J Cardiol
|
2009
|
0.76
|
335
|
How do we get there from here-is it safe and in whose hands?
|
J Cardiovasc Electrophysiol
|
2005
|
0.76
|
336
|
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
|
Am Heart J
|
2011
|
0.76
|
337
|
ACCF/AHA 2007 clinical competence statement on vascular imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training: developed in collaboration with the Society of Atherosclerosis Imaging and Prevention, the Society for Cardiovascular Angiography and Interventions, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society for Vascular Medicine and Biology.
|
Circulation
|
2007
|
0.76
|
338
|
Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction.
|
JAMA
|
2007
|
0.76
|
339
|
The international registry infrastructure for cardiovascular device evaluation and surveillance.
|
JAMA
|
2013
|
0.76
|
340
|
Three-dimensional printing of large nasal septal perforations for optimal prosthetic closure.
|
Am J Rhinol Allergy
|
2016
|
0.76
|
341
|
Pulmonary vein stenosis after atrial fibrillation ablation.
|
EuroIntervention
|
2016
|
0.75
|
342
|
Myocardial revascularization by percutaneous coronary intervention: past, present, and the future.
|
Curr Probl Cardiol
|
2011
|
0.75
|
343
|
Reply: Is CABG Superior to DES for Repeat Revascularization in Patients With Isolated Proximal LAD Disease?
|
J Am Coll Cardiol
|
2015
|
0.75
|
344
|
Letter by Tomaselli and Holmes regarding article, "2011 ASA/ACCF/AHA/AANN/AANS/ACR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease".
|
Circulation
|
2012
|
0.75
|
345
|
The process of bringing new drug-eluting stents to market will they see the light of day?
|
JACC Cardiovasc Interv
|
2008
|
0.75
|
346
|
Unprotected left main percutaneous coronary intervention.
|
Rev Cardiovasc Med
|
2002
|
0.75
|
347
|
Clinical and economic outcomes after introduction of drug-eluting stents.
|
Am J Manag Care
|
2010
|
0.75
|
348
|
Toward modeling of radio-frequency ablation lesions for image-guided left atrial fibrillation therapy: model formulation and preliminary evaluation.
|
Stud Health Technol Inform
|
2013
|
0.75
|
349
|
How did we get here from there?
|
Catheter Cardiovasc Interv
|
2003
|
0.75
|
350
|
Resistance to what, does it matter? How do we study it?
|
Eur Heart J
|
2008
|
0.75
|
351
|
Pulse transmission coefficient: a nonhyperemic index for physiologic assessment of procedural success following percutaneous coronary interventions.
|
Catheter Cardiovasc Interv
|
2004
|
0.75
|
352
|
Next-generation drug-eluting stents: a spirited step forward or more of the same.
|
JAMA
|
2008
|
0.75
|
353
|
Pulse transmission coefficient: a novel nonhyperemic parameter for assessing the physiological significance of coronary artery stenoses.
|
J Am Coll Cardiol
|
2002
|
0.75
|
354
|
Predictors of failure of endovascular therapy for peripheral arterial disease.
|
Angiology
|
2006
|
0.75
|
355
|
Bridging and spasming.
|
Tex Heart Inst J
|
2012
|
0.75
|
356
|
Cost-effectiveness of sirolimus-eluting stents compared with vascular brachytherapy for the treatment of in-stent restenosis.
|
Am Heart J
|
2007
|
0.75
|
357
|
Do we need a better mouse trap?
|
Eur Heart J
|
2010
|
0.75
|
358
|
Coronary artery fistula with anomalous coronary artery origin: a case report.
|
J Am Soc Echocardiogr
|
2007
|
0.75
|
359
|
A better way to get there?
|
Catheter Cardiovasc Interv
|
2007
|
0.75
|
360
|
Reply: Left Atrial Appendage Occlusion Devices Versus Pharmacological Agents for Stroke Prevention in Atrial Fibrillation.
|
J Am Coll Cardiol
|
2015
|
0.75
|
361
|
Guidelines, lighthouses, and a toe in the water.
|
Circulation
|
2005
|
0.75
|
362
|
Next generation drug-eluting stents: focus on bioabsorbable platforms and polymers.
|
Med Devices (Auckl)
|
2009
|
0.75
|
363
|
Interventional cardiology: A new drug-eluting stent that does not live up to its promise.
|
Nat Rev Cardiol
|
2009
|
0.75
|
364
|
Day in and day out.
|
Catheter Cardiovasc Interv
|
2004
|
0.75
|
365
|
Interventional cardiology: Don't neglect the octogenarians--DES for everyone!?
|
Nat Rev Cardiol
|
2012
|
0.75
|
366
|
Venn diagrams in cardiovascular disease: the Heart Team concept.
|
Eur J Cardiothorac Surg
|
2013
|
0.75
|
367
|
Lipid-rich plaque masquerading as a coronary thrombus.
|
Clin Med Res
|
2006
|
0.75
|
368
|
Coming close and then pulling away.
|
Eur Heart J
|
2007
|
0.75
|
369
|
Stenting small coronary arteries: works in progress.
|
JAMA
|
2004
|
0.75
|
370
|
A view from within.
|
Catheter Cardiovasc Interv
|
2004
|
0.75
|
371
|
Benefit with Impella?
|
J Am Coll Cardiol
|
2010
|
0.75
|
372
|
Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience.
|
Mayo Clin Proc
|
2009
|
0.75
|
373
|
A piecewise patch-to-model matching method for image-guided cardiac catheter ablation.
|
Comput Med Imaging Graph
|
2011
|
0.75
|
374
|
Appending Limited Clinical Data to an Administrative Database for Acute Myocardial Infarction Patients: The Impact on the Assessment of Hospital Quality.
|
Med Care
|
2016
|
0.75
|
375
|
The effect of HapMap on cardiovascular research and clinical practice.
|
Nat Clin Pract Cardiovasc Med
|
2007
|
0.75
|
376
|
Challenges of antiplatelet therapy in patients who require anticoagulation.
|
J Invasive Cardiol
|
2009
|
0.75
|
377
|
Patient selection for transcatheter aortic valve replacement.
|
J Am Coll Cardiol
|
2013
|
0.75
|
378
|
The clinical development of percutaneous heart valve technology.
|
J Thorac Cardiovasc Surg
|
2005
|
0.75
|
379
|
Angiography and interventional cardiology.
|
J Am Coll Cardiol
|
2004
|
0.75
|
380
|
President's page: Wrinkling the soul.
|
J Am Coll Cardiol
|
2011
|
0.75
|
381
|
Abciximab readministration.
|
Rev Cardiovasc Med
|
2002
|
0.75
|
382
|
ACCF/AHA 2011 health policy statement on therapeutic interchange and substitution: a report of the American College of Cardiology Foundation Clinical Quality Committee.
|
J Am Coll Cardiol
|
2011
|
0.75
|
383
|
Elective percutaneous coronary intervention without on-site cardiac surgery: clinical and economic implications.
|
Med Care
|
2006
|
0.75
|
384
|
President's page: clouds, science, and education.
|
J Am Coll Cardiol
|
2011
|
0.75
|
385
|
Evidence of a topographical link between unstable carotid plaques and luminal stenosis: can we better stratify asymptomatic patients with significant plaque burden?
|
Int J Cardiol
|
2011
|
0.75
|
386
|
Late DES thrombosis: a lot of smoke, very little fire?
|
Catheter Cardiovasc Interv
|
2007
|
0.75
|
387
|
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies.
|
EuroIntervention
|
2016
|
0.75
|
388
|
Academic technology transfer and radiology: a strong partnership for the future.
|
Acad Radiol
|
2007
|
0.75
|
389
|
Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis.
|
Catheter Cardiovasc Interv
|
2004
|
0.75
|
390
|
Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
|
Int J Cardiol
|
2013
|
0.75
|
391
|
Feasibility and effectiveness of massage therapy for symptom relief in cardiac catheter laboratory staff: a pilot study.
|
Complement Ther Clin Pract
|
2011
|
0.75
|
392
|
Percutaneous left atrial appendage obliteration.
|
JACC Cardiovasc Imaging
|
2008
|
0.75
|
393
|
Simulation: present and future roles.
|
JACC Cardiovasc Interv
|
2008
|
0.75
|
394
|
Integrated management of patients with diabetes mellitus and ischemic heart disease: PCI, CABG, and medical therapy.
|
Curr Probl Cardiol
|
2005
|
0.75
|
395
|
Left atrial appendage occlusion for stroke prevention.
|
Curr Probl Cardiol
|
2015
|
0.75
|
396
|
President's page: measuring and other things.
|
J Am Coll Cardiol
|
2011
|
0.75
|
397
|
Reply: Incomplete Revascularization in PCI and CABG: When Two Plus Two Does Not Make Four.
|
J Am Coll Cardiol
|
2016
|
0.75
|
398
|
Ethical issues in cardiovascular research involving humans.
|
Circulation
|
2009
|
0.75
|
399
|
Venn diagrams in cardiovascular disease: the Heart Team concept.
|
Ann Thorac Surg
|
2013
|
0.75
|
400
|
Interventional fellowship in structural and congenital heart disease for adults.
|
Catheter Cardiovasc Interv
|
2010
|
0.75
|
401
|
The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
|
JACC Cardiovasc Interv
|
2012
|
0.75
|
402
|
Residual leaks following percutaneous left atrial appendage occlusion: assessment and management implications.
|
EuroIntervention
|
2017
|
0.75
|
403
|
ACCF and AHA Presidents' Letter on MEDCAC.
|
J Am Coll Cardiol
|
2012
|
0.75
|
404
|
Coronary intervention in thrombus-rich lesions: beyond stents and glycoprotein IIb/IIIa inhibitors.
|
Isr Med Assoc J
|
2003
|
0.75
|
405
|
President's page: Having light, pass it on.
|
J Am Coll Cardiol
|
2007
|
0.75
|
406
|
Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
|
Catheter Cardiovasc Interv
|
2012
|
0.75
|
407
|
Axillary artery conduit formation for arterial access during transapical transcatheter aortic valve replacement.
|
J Card Surg
|
2014
|
0.75
|
408
|
Access site for cardiac catheterization.
|
Am Heart J
|
2004
|
0.75
|
409
|
Update on dual antiplatelet therapy for percutaneous coronary intervention.
|
Heart
|
2009
|
0.75
|
410
|
President's page: i2 Summit 2006: one-stop shopping for interventionalists.
|
J Am Coll Cardiol
|
2005
|
0.75
|
411
|
Delayed transcatheter heart valve migration and failure.
|
JACC Cardiovasc Imaging
|
2014
|
0.75
|
412
|
Percutaneous Transcatheter Biopsy for Intracardiac Mass Diagnosis.
|
EuroIntervention
|
2017
|
0.75
|
413
|
Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study.
|
EuroIntervention
|
2015
|
0.75
|
414
|
An update on transcatheter aortic valve replacement.
|
Curr Probl Cardiol
|
2013
|
0.75
|
415
|
Simulated imaging of atherosclerotic & radiofrequency ablation lesions using phase subtraction.
|
Conf Proc IEEE Eng Med Biol Soc
|
2015
|
0.75
|
416
|
Percutaneous left atrial appendage occlusion in 2016.
|
EuroIntervention
|
2016
|
0.75
|
417
|
President's page: acute coronary care: the yardstick of value.
|
J Am Coll Cardiol
|
2006
|
0.75
|
418
|
Prognostic implications of severe coronary calcification in patients undergoing coronary artery bypass surgery: an analysis of the SYNTAX study.
|
Catheter Cardiovasc Interv
|
2014
|
0.75
|
419
|
Fast adaptation of pre-operative patient specific models to real-time intra-operative volumetric data streams.
|
Stud Health Technol Inform
|
2011
|
0.75
|
420
|
Assessing hospital performance for acute myocardial infarction: how should emergency department transfers be attributed.
|
Med Care
|
2015
|
0.75
|
421
|
Anticipated impact of drug-eluting stents on referral patterns for coronary artery bypass graft surgery: a population-based angiographic analysis.
|
Mayo Clin Proc
|
2004
|
0.75
|
422
|
President's page: heroes and the shoulders of giants.
|
J Am Coll Cardiol
|
2012
|
0.75
|
423
|
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
|
Heart Surg Forum
|
2013
|
0.75
|
424
|
Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS).
|
EuroIntervention
|
2011
|
0.75
|
425
|
Unrestricted availability of intracoronary stents is associated with decreased abrupt vascular closure rates and improved early clinical outcomes.
|
Catheter Cardiovasc Interv
|
2002
|
0.75
|